Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM

NCT04471844 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

981

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DEVICE: Optune®

Sponsor

NovoCure Ltd.